Gonococcal conjunctivitis is a serious eye infection caused by the bacteria Neisseria gonorrhoeae. It is also known as gonorrhea of the eye, and can cause severe inflammation and pain. If left untreated, it can lead to serious complications, including blindness. In this article, we will take a closer look at gonococcal conjunctivitis, including its causes, symptoms, and treatment options.
Gonococcal conjunctivitis is an infection of the eye caused by the bacteria Neisseria gonorrhoeae. It is a sexually transmitted disease, and is most commonly spread through sexual contact. It can also be spread through contact with infected secretions, such as semen or vaginal fluid. It can also be spread through contact with contaminated objects, such as towels or bedding. Gonococcal conjunctivitis can affect both eyes, but is more commonly seen in one eye. It is most common in adults, but can also affect children and infants.
The most common symptom of gonococcal conjunctivitis is redness of the eye. Other symptoms may include pain, itching, discharge, and swelling. In some cases, the infection can cause blurred vision or sensitivity to light.
Gonococcal conjunctivitis is caused by the bacteria Neisseria gonorrhoeae. This bacteria is spread through sexual contact or contact with infected secretions, such as semen or vaginal fluid. It can also be spread through contact with contaminated objects, such as towels or bedding.
The risk of developing gonococcal conjunctivitis increases with certain behaviors and conditions. These include: • Having unprotected sex • Having multiple sexual partners • Having a history of sexually transmitted infections • Having a weakened immune system • Having contact with an infected person
Gonococcal conjunctivitis is diagnosed through a physical examination and laboratory tests. During the physical exam, the doctor will check for signs of infection, such as redness, swelling, and discharge. The doctor may also take a swab of the discharge to test for the presence of the bacteria Neisseria gonorrhoeae.
Gonococcal conjunctivitis is treated with antibiotics. These antibiotics can be taken orally or applied topically to the eye. It is important to follow the doctor’s instructions carefully and finish all of the medication, even if the symptoms have improved.
The best way to prevent gonococcal conjunctivitis is to practice safe sex and to avoid contact with infected secretions or contaminated objects. It is also important to get tested for sexually transmitted infections regularly.
Gonococcal conjunctivitis is a serious eye infection caused by the bacteria Neisseria gonorrhoeae. It is most commonly spread through sexual contact or contact with infected secretions. It can cause severe inflammation and pain, and can lead to serious complications if left untreated. The best way to prevent gonococcal conjunctivitis is to practice safe sex and to avoid contact with infected secretions or contaminated objects. Treatment for gonococcal conjunctivitis usually involves antibiotics, and it is important to finish all of the medication, even if the symptoms have improved.
1.
Q&A: When will individuals be able to receive customized cancer vaccines?
2.
Canadian Group Calls for Earlier Colorectal Cancer Screening
3.
Children living near oil and gas wells face higher risk of rare leukemia, studies show
4.
Researchers achieve a significant milestone in the management of anemia in chronic lymphocytic leukemia.
5.
Talquetamab Combos Show Survival Benefit in r/r Myeloma
1.
Liquid Biopsy: A Revolutionary Tool for Early Detection and Monitoring of Colorectal Cancer
2.
Clinical Pharmacology of Megakaryocyte Maturation-Targeted Therapeutics
3.
The Benefits and Side Effects of Bortezomib in the Fight Against Cancer
4.
Personalized Tumor Ecological Landscapes in Oncology
5.
Unmasking the Subtle Symptoms of Colon Cancer
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II
3.
Current Scenario of Cancer- Q&A Session to Close the Gap Part II
4.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
5.
Immunotherapy: A New Era in Cancer Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation